Gui Ying Zhao
Director/Board Member bij SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD.
Profiel
Gui Ying Zhao is currently holding three positions as Vice Chairman at China Quality Association For Pharmaceuticals, Independent Director at Shanghai Rightongene Biotechnology Co., Ltd., and Independent Non-Executive Director at IVF Hospital Management Group Ltd.
In the past, Ms. Zhao worked as an Independent Class III Director at MYOS RENS Technology, Inc. Ms. Zhao completed an undergraduate degree at China Pharmaceutical University.
Actieve functies van Gui Ying Zhao
| Bedrijven | Functie | Begin |
|---|---|---|
| SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD. | Director/Board Member | 13-12-2018 |
| China Quality Association For Pharmaceuticals | Director/Board Member | 01-01-2006 |
IVF Hospital Management Group Ltd.
 IVF Hospital Management Group Ltd. MiscellaneousMiscellaneous IVF Hospital Management Group Ltd. operates as an investment holding company. It mainly involves in the provision of assisted reproductive technology (ART) and ancillary services. The company was founded by Ren Jiz Hong on September 5, 2006 and is headquartered in Shenzhen, China. | Director/Board Member | 01-11-2021 |
Eerdere bekende functies van Gui Ying Zhao
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDAVAIL HOLDINGS, INC. | Director/Board Member | 23-08-2016 |
Opleiding van Gui Ying Zhao
| China Pharmaceutical University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
MYOS RENS Technology, Inc.
 MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ. | Health Technology |
| China Quality Association For Pharmaceuticals | |
IVF Hospital Management Group Ltd.
IVF Hospital Management Group Ltd. MiscellaneousMiscellaneous IVF Hospital Management Group Ltd. operates as an investment holding company. It mainly involves in the provision of assisted reproductive technology (ART) and ancillary services. The company was founded by Ren Jiz Hong on September 5, 2006 and is headquartered in Shenzhen, China. | Miscellaneous |
